IndraLab

Statements


| 3

reach
"Khandoudi N, Delerive P, Berrebi-Bertrand I, Buckingham RE, Staels B, Bril A. Rosiglitazone, a peroxisome proliferator activated receptor-gamma, inhibits the Jun NH (2)-terminal kinase and activating protein 1 pathway and protects the heart from ischemia / reperfusion injury."

reach
"Khandoudi N, Delerive P, Berrebi-Bertrand I, Buckingham RE, Staels B, Bril A. Rosiglitazone, a peroxisome proliferatoractivated receptor-gamma, inhibits the Jun NH (2)-terminal kinase and activating protein 1 pathway and protects the heart from ischemia / reperfusion injury."

reach
"Rosiglitazone, a peroxisome proliferator activated receptor-gamma, inhibits the Jun NH (2)-terminal kinase and activating protein 1 pathway and protects the heart from ischemia and reperfusion injury."